🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the efficacy and safety of three ...
Status
Completed
Location
National University Hospital - Allergy Unit 4222
Start Date
2008-10
Trial ID
NCT00901914
Aim of this study is to use the major allergen 1 of birch-tree pollen (Bet ...
Status
Completed
Location
Medical University of Vienna
Start Date
2011-02
Trial ID
NCT02098551
Treatments Being Tested
Specific immunotherapy with recombinant birch pollen allergen rBet v1-FV...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2003-07
Trial ID
NCT00266526
Treatments Being Tested
The only disease-modifying treatment for allergic disorders nowadays is all...
Status
Unknown
Location
Medical University of Vienna, Department of Pathophysiology
Start Date
2011-08
Trial ID
NCT01353924
Treatments Being Tested
More than 70% of birch pollen allergic patients suffer from allergic reacti...
Status
Completed
Location
Medical University of Vienna
Start Date
2012-03-14
Trial ID
NCT01449786
Treatments Being Tested
In this study, participants will receive either intranasal anti-IgE-antibod...
Status
Completed
Location
Dept. of Otorhinolaryngology, Medical University of Vienna
Start Date
2012-11
Trial ID
NCT03019237
Treatments Being Tested
Efficacy and Safety from a recombinant folding variant of Bet v 1...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2007-09
Trial ID
NCT00554983
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of se...
Status
Completed
Location
National University Hospital - Allergy Unit 4222
Start Date
2007-11
Trial ID
NCT00889460
To investigate the safety and tolerability of successive single rising dose...
Status
Completed
Location
National University Hospital - Allergy Unit 4222
Start Date
2006-11
Trial ID
NCT00396149